Calling early-stage clinician scientists! Be part of the cure for #Neurofibromatosis. Join the leaders shaping #NF1 research & care. Deadline: 19 days away! Apply now: Francis S. Collins Scholars Program | Neurofibromatosis Research | NTAP (https://t.co/Cpsk8cREYA)
#NF1Therapies
Thanks to incredible work by Indian experts, a study conducted on the Immediate Kangaroo Mother Care (IKMC) method in India, reveals some amazing findings about saving newborn lives. Such innovations have the potential to save countless lives globally. @narendramodi@JPNadda
Handy guide for data enthusiasts at #AAIC24:
🏛️ Sage Bionetworks is a non-profit where people work
🛠️ Synapse is their software system for managing data
📊 The AD Knowledge Portal is the web page where you can find AD data
Adding to the excitement of the #AI session at the @ChildrensTumor global NF conference, @gwaybio presents how #cellpainting can be used to identify #NF1 loss/rescue in a drug screening context.
@sargoshoe talks about how they are using @nfopensci NF Data Portal data to develop Coderdata models for drug sensitivity prediction for deadly MPNSTs at the @ChildrensTumor global NF conference 2024.
@sargoshoe@GreeneScientist It was such a wonderful collaboration with @allawayr and @sargoshoe to apply this to NF data from the NF Data Portal.. the power of data sharing and data re-use
Here @GreeneScientist is talking about using matrix factorization to enable transfer learning across rare disease datasets, an approach that @jinetab used in our work on #NF1 tumors https://t.co/ctSiNqTPoL
Are you attending #nfcon24 ? Come and meet us! We'll be hosting focused workshops on how to access and reuse datasets from our NF data portal, and on how to use AI tools to curate this data @nfopensci
We’re committed to truly open data, not just in appearance only. We've initiated a collab w/ @awscloud to increase access to popular biomedical datasets on our Synapse platform. Users can readily reuse these data in ways to transform science & medicine.
https://t.co/x2xSgtl7EY
After decades of slow progress, it was public-private partnerships that led to the first approved therapy for #neurofibromatosis.
Annette Bakker shows how @ChildrensTumor has become a model of this type of funding, and how others can follow. @nfopensci
https://t.co/TlBpSAdRU3
Today we unveil our new look and brand new website!
It reflects our drive beyond data sharing and towards data reuse. The goal? Bridging and powering multidisciplinary communities to forge a new path towards optimal human health.
Explore our interactive https://t.co/k2cxRX89wW
We need predictive biomarkers of drug efficacy for aggressive cancers.
@DR_E_A_M challenge is 1st successful attempt to use protected clinical data for crowdsourcing predictive models for immune checkpoint inhibitor efficacy in #lungcancer https://t.co/ooQMZ9zdMQ @BioMedCentral
I'm hiring a VP of Technology at @Sagebio to help us bridge the gap between biomedical data sharing and actual reuse!
Skill/interests/experience:
▶️ biomedical big data management
▶️ LLM-powered search & data annotation
▶️ product development
Join us!
https://t.co/q1kLGyhLeA
Data sharing doesn’t mean reuse 👏👏
Data sharing doesn’t mean reuse 👏👏
Data sharing doesn’t mean reuse 👏👏
Listing your data on an open repository is good.
Getting it into another person’s notebook is a totally different story.
Make biomedical data reuse your priority!💪
Here are my 12 guidelines for data exploration and analysis with the right attitude for discovery:
1. You never really finish analyzing a dataset. You just decide to stop and move on at some point, leaving some things undiscovered. 🧵